1887

Abstract

Human herpesvirus 6B (HHV-6B) contains an domain spanning open reading frames , based on homology with human cytomegalovirus. Here, the protein product, U19, of the HHV-6B gene is identified as a 47 kDa transcriptional activator. HHV-6B infection or overexpression of U19 transactivated the RANTES promoter. Mutational analysis of the promoter indicated that transactivation was not critically dependent on the promoter sites CRE, NF-B, ISRE or NF-IL6. ND10 are nuclear substructures that are involved in several cellular regulatory pathways, including those controlling gene expression. HHV-6B infection resulted in a reduced number of ND10 structures, but with a concomitantly increased level of promyelocytic leukaemia (PML) protein expression and mRNA induction. The U19 protein co-located to ND10 with PML and heterochromatin protein 1 (HP1), but whilst PML formed a ring structure, U19 also localized to the centre of ND10. Knockdown of PML by small interfering RNA did not prevent U19 localization to ND10-like foci, but instead led to a fourfold increase in U19-induced transcription from the RANTES promoter. Generation of four truncated U19 proteins indicated that the N-terminal portion of the protein contains a sequence responsible for nuclear localization; a domain in the N-terminal half of U19 is responsible for its ND10 localization, whereas the C-terminal portion contains the transactivation domain. None of the truncated proteins retained full transactivating ability on the RANTES promoter. Thus, U19 is a transcriptional activator that co-localizes with PML and localizes to ND10-like foci independently of PML, yet is regulated negatively by PML or its associated proteins.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83224-0
2008-01-01
2020-01-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/1/106.html?itemId=/content/journal/jgv/10.1099/vir.0.83224-0&mimeType=html&fmt=ahah

References

  1. Ahn, J. H., Jang, W. J. & Hayward, G. S. ( 1999; ). The human cytomegalovirus IE2 and UL112–113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J Virol 73, 10458–10471.
    [Google Scholar]
  2. Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K. & Pelicci, P. G. ( 1998; ). The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 18, 1084–1093.
    [Google Scholar]
  3. Bartova, E., Pachernik, J., Kozubik, A. & Kozubek, S. ( 2007; ). Differentiation-specific association of HP1α and HP1β with chromocentres is correlated with clustering of TIF1β at these sites. Histochem Cell Biol 127, 375–388.[CrossRef]
    [Google Scholar]
  4. Boisvert, F. M., Kruhlak, M. J., Box, A. K., Hendzel, M. J. & Bazett-Jones, D. P. ( 2001; ). The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol 152, 1099–1106.[CrossRef]
    [Google Scholar]
  5. Caruso, A., Favilli, F., Rotola, A., Comar, M., Horejsh, D., Alessandri, G., Grassi, M., Di, L. D. & Fiorentini, S. ( 2003; ). Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J Med Virol 70, 451–458.[CrossRef]
    [Google Scholar]
  6. Casola, A., Garofalo, R. P., Haeberle, H., Elliott, T. F., Lin, R., Jamaluddin, M. & Brasier, A. R. ( 2001; ). Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. J Virol 75, 6428–6439.[CrossRef]
    [Google Scholar]
  7. Chan, P. K., Ng, H. K., Hui, M. & Cheng, A. F. ( 2001; ). Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J Med Virol 64, 42–46.[CrossRef]
    [Google Scholar]
  8. Chelbi-Alix, M. K. & De, T. H. ( 1999; ). Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18, 935–941.[CrossRef]
    [Google Scholar]
  9. Colberg-Poley, A. M., Santomenna, L. D., Harlow, P. P., Benfield, P. A. & Tenney, D. J. ( 1992; ). Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J Virol 66, 95–105.
    [Google Scholar]
  10. Csoma, E., Deli, T., Konya, J., Csernoch, L., Beck, Z. & Gergely, L. ( 2006; ). Human herpesvirus 6A decreases the susceptibility of macrophages to R5 variants of human immunodeficiency virus 1: possible role of RANTES and IL-8. Virus Res 121, 161–168.[CrossRef]
    [Google Scholar]
  11. Dellaire, G. & Bazett-Jones, D. P. ( 2004; ). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963–977.[CrossRef]
    [Google Scholar]
  12. Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N. & Pellett, P. E. ( 1999; ). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73, 8040–8052.
    [Google Scholar]
  13. Donati, D., Martinelli, E., Cassiani-Ingoni, R., Ahlqvist, J., Hou, J., Major, E. O. & Jacobson, S. ( 2005; ). Variant-specific tropism of human herpesvirus 6 in human astrocytes. J Virol 79, 9439–9448.[CrossRef]
    [Google Scholar]
  14. Everett, R. D. ( 2001; ). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266–7273.[CrossRef]
    [Google Scholar]
  15. Everett, R. D. ( 2006; ). Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 8, 365–374.[CrossRef]
    [Google Scholar]
  16. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T. & Orr, A. ( 2006; ). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80, 7995–8005.[CrossRef]
    [Google Scholar]
  17. Gompels, U. A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B. J., Martin, M. E., Efstathiou, S., Craxton, M. & Macaulay, H. A. ( 1995; ). The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209, 29–51.[CrossRef]
    [Google Scholar]
  18. Gravel, A., Gosselin, J. & Flamand, L. ( 2002; ). Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies. J Biol Chem 277, 19679–19687.[CrossRef]
    [Google Scholar]
  19. He, J., McCarthy, M., Zhou, Y., Chandran, B. & Wood, C. ( 1996; ). Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70, 1296–1300.
    [Google Scholar]
  20. Isegawa, Y., Mukai, T., Nakano, K., Kagawa, M., Chen, J., Mori, Y., Sunagawa, T., Kawanishi, K. & Sashihara, J. ( 1999; ). Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73, 8053–8063.
    [Google Scholar]
  21. Ishov, A. M. & Maul, G. G. ( 1996; ). The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134, 815–826.[CrossRef]
    [Google Scholar]
  22. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F. & Maul, G. G. ( 1999; ). PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221–234.[CrossRef]
    [Google Scholar]
  23. Josephs, S. F., Salahuddin, S. Z., Ablashi, D. V., Schachter, F., Wong-Staal, F. & Gallo, R. C. ( 1986; ). Genomic analysis of the human B-lymphotropic virus (HBLV). Science 234, 601–603.[CrossRef]
    [Google Scholar]
  24. Kumar, P. P., Bischof, O., Purbey, P. K., Notani, D., Urlaub, H., Dejean, A. & Galande, S. ( 2007; ). Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9, 45–56.[CrossRef]
    [Google Scholar]
  25. Luciani, J. J., Depetris, D., Usson, Y., Metzler-Guillemain, C., Mignon-Ravix, C., Mitchell, M. J., Megarbane, A., Sarda, P., Sirma, H. & other authors ( 2006; ). PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci 119, 2518–2531.[CrossRef]
    [Google Scholar]
  26. Luppi, M., Barozzi, P., Morris, C., Maiorana, A., Garber, R., Bonacorsi, G., Donelli, A., Marasca, R., Tabilio, A. & other authors ( 1999; ). Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol 73, 754–759.
    [Google Scholar]
  27. Lusso, P., Malnati, M., De, M. A., Balotta, C., DeRocco, S. E., Markham, P. D. & Gallo, R. C. ( 1991; ). Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 147, 685–691.
    [Google Scholar]
  28. Lusso, P., Malnati, M. S., Garzino-Demo, A., Crowley, R. W., Long, E. O. & Gallo, R. C. ( 1993; ). Infection of natural killer cells by human herpesvirus 6. Nature 362, 458–462.[CrossRef]
    [Google Scholar]
  29. Mirandola, P., Menegazzi, P., Merighi, S., Ravaioli, T., Cassai, E. & Di, L. D. ( 1998; ). Temporal mapping of transcripts in herpesvirus 6 variants. J Virol 72, 3837–3844.
    [Google Scholar]
  30. Nicholas, J. & Martin, M. E. ( 1994; ). Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions. J Virol 68, 597–610.
    [Google Scholar]
  31. Okuno, T., Takahashi, K., Balachandra, K., Shiraki, K., Yamanishi, K., Takahashi, M. & Baba, K. ( 1989; ). Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 27, 651–653.
    [Google Scholar]
  32. Øster, B. & Höllsberg, P. ( 2002; ). Viral gene expression patterns in human herpesvirus 6B-infected T cells. J Virol 76, 7578–7586.[CrossRef]
    [Google Scholar]
  33. Øster, B., Kaspersen, M. D., Kofod-Olsen, E., Bundgaard, B. & Höllsberg, P. ( 2006; ). Human herpesvirus 6B inhibits cell proliferation by a p53-independent pathway. J Clin Virol 37, S63–68.[CrossRef]
    [Google Scholar]
  34. Pampin, M., Simonin, Y., Blondel, B., Percherancier, Y. & Chelbi-Alix, M. K. ( 2006; ). Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol 80, 8582–8592.[CrossRef]
    [Google Scholar]
  35. Papanikolaou, E., Kouvatsis, V., Dimitriadis, G., Inoue, N. & Arsenakis, M. ( 2002; ). Identification and characterization of the gene products of open reading frame U86/87 of human herpesvirus 6. Virus Res 89, 89–101.[CrossRef]
    [Google Scholar]
  36. Sadanari, H., Yamada, R., Ohnishi, K., Matsubara, K. & Tanaka, J. ( 2005; ). SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein. Arch Virol 150, 1763–1782.[CrossRef]
    [Google Scholar]
  37. Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfield, P., Wong-Staal, F. & other authors ( 1986; ). Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234, 596–601.[CrossRef]
    [Google Scholar]
  38. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A. & Lusso, P. ( 1999; ). CD46 is a cellular receptor for human herpesvirus 6. Cell 99, 817–827.[CrossRef]
    [Google Scholar]
  39. Schirmer, E. C., Wyatt, L. S., Yamanishi, K., Rodriguez, W. J. & Frenkel, N. ( 1991; ). Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci U S A 88, 5922–5926.[CrossRef]
    [Google Scholar]
  40. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. & Pandolfi, P. P. ( 2006; ). The mechanisms of PML-nuclear body formation. Mol Cell 24, 331–339.[CrossRef]
    [Google Scholar]
  41. Stanton, R., Fox, J. D., Caswell, R., Sherratt, E. & Wilkinson, G. W. ( 2002; ). Analysis of the human herpesvirus-6 immediate-early 1 protein. J Gen Virol 83, 2811–2820.
    [Google Scholar]
  42. Takeda, K., Nakagawa, N., Yamamoto, T., Inagi, R., Kawanishi, K., Isegawa, Y. & Yamanishi, K. ( 1996; ). Prokaryotic expression of an immediate-early gene of human herpesvirus 6 and analysis of its viral antigen expression in human cells. Virus Res 41, 193–200.[CrossRef]
    [Google Scholar]
  43. Tavalai, N., Papior, P., Rechter, S., Leis, M. & Stamminger, T. ( 2006; ). Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80, 8006–8018.[CrossRef]
    [Google Scholar]
  44. Tomoiu, A., Gravel, A., Tanguay, R. M. & Flamand, L. ( 2006; ). Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. J Virol 80, 10218–10228.[CrossRef]
    [Google Scholar]
  45. Vallian, S., Chin, K. V. & Chang, K. S. ( 1998; ). The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol Cell Biol 18, 7147–7156.
    [Google Scholar]
  46. Ward, K. N., Gray, J. J., Fotheringham, M. W. & Sheldon, M. J. ( 1993; ). IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. J Med Virol 39, 131–138.[CrossRef]
    [Google Scholar]
  47. Wu, W. S., Vallian, S., Seto, E., Yang, W. M., Edmondson, D., Roth, S. & Chang, K. S. ( 2001; ). The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol 21, 2259–2268.[CrossRef]
    [Google Scholar]
  48. Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. & Kurata, T. ( 1988; ). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1, 1065–1067.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83224-0
Loading
/content/journal/jgv/10.1099/vir.0.83224-0
Loading

Data & Media loading...

Supplements

vol. , part 1, pp. 106 – 116

Primers used for PCR, real-time PCR and sequencing [ PDF] (119 KB)



PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error